Chlordiazepoxide
Elenium contains the active substance chlordiazepoxide, which belongs to a group of medicines called benzodiazepines. Chlordiazepoxide has anxiolytic, sedative, moderately hypnotic, and muscle relaxant properties. Elenium is used for a short period (2 to 4 weeks) in the treatment of:
If the patient has:
General information about the effects observed after treatment with benzodiazepines and other medicines with similar effects to benzodiazepines, which should be taken into account when taking Elenium.
Tolerance
After taking Elenium for several weeks, its effectiveness may decrease.
Dependence
Taking Elenium for a longer period may lead to psychological and physical dependence.
The risk of developing dependence increases with the increase in dose and treatment time and is higher in patients addicted to drugs, alcohol, or narcotics, or in patients with personality disorders.
Withdrawal symptoms
After sudden withdrawal of the medicine, the patient may experience withdrawal symptoms, such as headaches, muscle pain, increased anxiety, tension, excitement, restlessness, disorientation, sleep disturbances, irritability.
In severe cases, the following may occur: loss of sense of reality, personality disorders, hypersensitivity to sound, touch, light, noise, feeling of tingling and numbness of limbs, hallucinations, and delusions, epileptic seizures.
Rebound phenomenon and anxiety
When discontinuing Elenium, a transient recurrence of intensified symptoms that were the reason for taking the medicine (so-called rebound phenomenon) may occur.
These symptoms are often accompanied by mood changes, anxiety, sleep disturbances, and insomnia.
To minimize the risk of these symptoms, it is recommended to gradually reduce the dose of the medicine.
Anterograde amnesia (inability to remember events after taking the medicine)
Elenium may cause anterograde amnesia (difficulty learning and remembering new information - new data is not permanently stored).
This condition usually occurs within a few hours of taking the medicine, especially in high doses.
If the doctor has prescribed Elenium to be taken once a day, to reduce the risk of anterograde amnesia, it is recommended to take the medicine 30 minutes before going to bed and ensure adequate conditions for continuous, uninterrupted sleep lasting 7-8 hours.
Psychological and paradoxical reactions
In children and the elderly, the risk of abnormal psychological and paradoxical reactions (opposite to expected) increases, such as anxiety, agitation, irritability, aggression, outbursts of anger, delusions, nightmares, hallucinations, psychoses, and behavioral disorders.
If such symptoms occur, the patient should immediately contact their doctor.
Use in depression
Before taking Elenium, the patient should inform their doctor about any mental illnesses and any attempted suicides.
Administering Elenium to such patients may exacerbate symptoms of depression, including suicidal thoughts.
Specific patient groups
Elderly patients should receive lower doses of Elenium (see section 3), due to the possibility of increased side effects, mainly orientation and motor coordination disorders (falls, injuries).
Children and adolescents - the safety and efficacy of the medicine have not been established in children and adolescents under 18 years of age, therefore, the use of the medicine in this age group is not recommended.
If the patient has any of the following conditions, they should inform their doctor before taking the medicine:
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
This is especially important if the patient is taking any of the following medicines:
If the doctor prescribes Elenium concomitantly with opioids, they should limit the dose and duration of concomitant treatment.
The patient should inform their doctor about all opioid medicines they are taking and strictly follow the doctor's instructions regarding dosage.
It may be helpful to inform friends or relatives to be aware of the possibility of these symptoms.
If such symptoms occur, the patient should contact their doctor.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.
Elenium should not be taken during pregnancy.
Chlordiazepoxide passes into breast milk. If administration is necessary, breastfeeding should be discontinued.
During treatment with Elenium, the patient should not drive vehicles or operate machinery.
The ability to drive vehicles and operate machinery may be impaired due to drowsiness, impaired concentration, or other side effects that reduce concentration (see section 4. Possible side effects).
Elenium contains lactose monohydrate and sucrose.
Elenium 5 mg or 10 mg or 25 mg contains lactose monohydrate and sucrose. If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
Elenium 5 mg or 10 mg or 25 mg contains less than 1 mmol (23 mg) of sodium per scored tablet, which means the medicine is considered "sodium-free".
Elenium 25 mg contains orange yellow S (E110), which may cause allergic reactions.
This medicine should always be taken according to the doctor's instructions.
In case of doubts, the patient should consult their doctor or pharmacist.
It is not recommended to use chlordiazepoxide in children.
The doctor determines the dosage individually for each patient, depending on the degree of dysfunction of the given organ.
Elderly patients are more sensitive to medicines that act on the central nervous system.
When taking Elenium in this population, it is recommended to administer the smallest effective dose. The dose should not exceed half of the recommended dose for adults.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
The duration of treatment is determined by the doctor.
Elenium tablets should be swallowed, washed down with a small amount of water.
The doctor will start treatment with the smallest effective dose and, if necessary, will gradually increase it.
Symptoms of overdose are impaired consciousness, drowsiness, confusion, slurred speech. In severe cases of poisoning, the following may occur: ataxia, hypotension, muscle weakness, respiratory disorders, coma, and even death.
If a higher dose of Elenium than recommended is taken, the patient should immediately contact their doctor or go to the nearest emergency department in a hospital. The patient should take the medicine in its original packaging so that the medical staff can precisely check which medicine was taken.
If the patient forgets to take a dose of the medicine, they should take the next dose as soon as they remember. However, if it is almost time for the next dose, the patient should skip the missed dose and take the next dose according to the recommended schedule. If the patient forgets to take two or more doses, they should contact their doctor.
The patient should not take a double dose to make up for a missed dose.
The patient should not stop taking Elenium unless it is in accordance with their doctor's instructions. It is possible that the symptoms of the disease will recur. If the doctor decides to discontinue treatment with Elenium, the dose of the medicine should be gradually reduced over several days.
In case of doubts related to the use of the medicine, the patient should consult their doctor.
Like all medicines, Elenium can cause side effects, although not everybody gets them.
If any of the following side effects occur, the patient should immediatelyinform their doctor or go to the nearest emergency department in a hospital:
The following side effects occur frequently(less than 1 in 10 patients)
The following side effects occur rarely(less than 1 in 1,000 patients)
The following side effects occur very rarely(less than 1 in 10,000 patients)
Frequency not known (cannot be estimated from the available data)
If any side effects occur, including any not listed in this leaflet, the patient should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, it is possible to gather more information on the safety of the medicine.
Keep out of sight and reach of children.
Store in a temperature below 25°C. Protect from light and moisture.
Do not use the medicine after the expiry date (EXP) stated on the packaging. The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.
The active substance of the medicine is chlordiazepoxide.
One tablet contains 5 mg of chlordiazepoxide.
Other ingredients are: potato starch, sodium carboxymethyl starch (type A), gelatin, polysorbate 80, talc, magnesium stearate, lactose monohydrate.
Coating ingredients: polyvinyl alcohol, talc, maltodextrin, quinoline yellow (E104), titanium dioxide, opaglos 6000, sucrose.
One tablet contains 10 mg of chlordiazepoxide.
Other ingredients are: potato starch, sodium carboxymethyl starch (type A), gelatin, polysorbate 80, talc, magnesium stearate, lactose monohydrate.
Coating ingredients: polyvinyl alcohol, talc, maltodextrin, indigo carmine (E132) + quinoline yellow (E104), titanium dioxide, opaglos 6000, sucrose.
One tablet contains 25 mg of chlordiazepoxide.
Other ingredients are: potato starch, sodium carboxymethyl starch (type A), gelatin, polysorbate 80, talc, magnesium stearate, lactose monohydrate.
Coating ingredients: polyvinyl alcohol, talc, maltodextrin, orange yellow S (E110), titanium dioxide, opaglos 6000, sucrose.
Elenium, 5 mg: yellow scored tablets, round, biconvex.
Elenium, 10 mg: green scored tablets, round, biconvex.
Elenium, 25 mg: orange scored tablets, round, biconvex.
Packaging:20 scored tablets.
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., ul. A. Fleminga 2, 03-176 Warsaw, phone: 22 811-18-14. For more detailed information, please contact the representative of the marketing authorization holder.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.